Showing results (41-50 of 160) with videos related to
Sort By:
Pageof 16
Kidney International|January 28, 2019
Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factorsJun Li, Julia Koerner, Michael Basler, et al.Immunogenetics|March 7, 2018
The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functionsRichard Schregle, Mei Min Mah, Stefanie Mueller, et al.Cell|March 5, 2013
Immuno- and constitutive proteasomes do not differ in their abilities to degrade ubiquitinated proteinsJames A Nathan, Valentina Spinnenhirn, Gunter Schmidtke, et al.ACS Central Science|March 4, 2020
Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S ProteasomeAtul Pawar, Michael Basler, Heike Goebel, et al.British Journal of Pharmacology|October 17, 2017
Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasomeMichael Basler, Elmer Maurits, Gerjan de Bruin, et al.EMBO Molecular Medicine|January 9, 2014
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitisMichael Basler, Sarah Mundt, Tony Muchamuel, et al.Cell|February 21, 2012
Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificityEva M Huber, Michael Basler, Ricarda Schwab, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2012
Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentationMichael Basler, Christoph Lauer, Jacqueline Moebius, et al.Sub-Cellular Biochemistry|January 12, 2011
FAT10 : Activated by UBA6 and Functioning in Protein DegradationChristiane Pelzer, Marcus GroettrupThe International Journal of Biochemistry & Cell Biology|July 10, 2016
The ubiquitin-like modifier FAT10 in cancer developmentAnnette Aichem, Marcus GroettrupPageof 16